PMC:7212949 / 76712-77646 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T650","span":{"begin":41,"end":50},"obj":"Disease"},{"id":"T651","span":{"begin":399,"end":408},"obj":"Disease"},{"id":"T652","span":{"begin":515,"end":524},"obj":"Disease"}],"attributes":[{"id":"A650","pred":"mondo_id","subj":"T650","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A651","pred":"mondo_id","subj":"T651","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A652","pred":"mondo_id","subj":"T652","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"Pregnant women with symptomatic MERS-CoV infection may be at a higher risk of adverse events. There are 9 reported cases of symptomatic MERS-CoV in pregnant women, and 7 of them required ICU admission, 5 required mechanical ventilation, and 3 died (Table 8).138 One case report of a term delivery in a recovered patient and another report of a patient delivered preterm while in the active phase of infection showed negative viral testing in the infant.138 , 139 There are 2 reported cases of asymptomatic MERS-CoV infection in pregnant women, both identified via contact tracing. One was identified at 6 weeks gestation, and the other at 24 weeks. Both had healthy term deliveries.140 Based on available epidemiologic data, it is unclear whether pregnant women with MERS-CoV have worse outcomes, though 3 deaths among eleven reported cases are concerning compared to an 8.9% death rate reported in a nonpregnant female population.141"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T795","span":{"begin":61,"end":62},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T796","span":{"begin":281,"end":282},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T797","span":{"begin":300,"end":301},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T798","span":{"begin":342,"end":343},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T799","span":{"begin":383,"end":389},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T800","span":{"begin":431,"end":438},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T801","span":{"begin":899,"end":900},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T802","span":{"begin":913,"end":919},"obj":"http://purl.obolibrary.org/obo/UBERON_0003100"}],"text":"Pregnant women with symptomatic MERS-CoV infection may be at a higher risk of adverse events. There are 9 reported cases of symptomatic MERS-CoV in pregnant women, and 7 of them required ICU admission, 5 required mechanical ventilation, and 3 died (Table 8).138 One case report of a term delivery in a recovered patient and another report of a patient delivered preterm while in the active phase of infection showed negative viral testing in the infant.138 , 139 There are 2 reported cases of asymptomatic MERS-CoV infection in pregnant women, both identified via contact tracing. One was identified at 6 weeks gestation, and the other at 24 weeks. Both had healthy term deliveries.140 Based on available epidemiologic data, it is unclear whether pregnant women with MERS-CoV have worse outcomes, though 3 deaths among eleven reported cases are concerning compared to an 8.9% death rate reported in a nonpregnant female population.141"}

    LitCovid-PD-GO-BP

    {"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T96","span":{"begin":611,"end":620},"obj":"http://purl.obolibrary.org/obo/GO_0007565"}],"text":"Pregnant women with symptomatic MERS-CoV infection may be at a higher risk of adverse events. There are 9 reported cases of symptomatic MERS-CoV in pregnant women, and 7 of them required ICU admission, 5 required mechanical ventilation, and 3 died (Table 8).138 One case report of a term delivery in a recovered patient and another report of a patient delivered preterm while in the active phase of infection showed negative viral testing in the infant.138 , 139 There are 2 reported cases of asymptomatic MERS-CoV infection in pregnant women, both identified via contact tracing. One was identified at 6 weeks gestation, and the other at 24 weeks. Both had healthy term deliveries.140 Based on available epidemiologic data, it is unclear whether pregnant women with MERS-CoV have worse outcomes, though 3 deaths among eleven reported cases are concerning compared to an 8.9% death rate reported in a nonpregnant female population.141"}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T772","span":{"begin":0,"end":93},"obj":"Sentence"},{"id":"T773","span":{"begin":94,"end":580},"obj":"Sentence"},{"id":"T774","span":{"begin":581,"end":648},"obj":"Sentence"},{"id":"T775","span":{"begin":649,"end":934},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Pregnant women with symptomatic MERS-CoV infection may be at a higher risk of adverse events. There are 9 reported cases of symptomatic MERS-CoV in pregnant women, and 7 of them required ICU admission, 5 required mechanical ventilation, and 3 died (Table 8).138 One case report of a term delivery in a recovered patient and another report of a patient delivered preterm while in the active phase of infection showed negative viral testing in the infant.138 , 139 There are 2 reported cases of asymptomatic MERS-CoV infection in pregnant women, both identified via contact tracing. One was identified at 6 weeks gestation, and the other at 24 weeks. Both had healthy term deliveries.140 Based on available epidemiologic data, it is unclear whether pregnant women with MERS-CoV have worse outcomes, though 3 deaths among eleven reported cases are concerning compared to an 8.9% death rate reported in a nonpregnant female population.141"}

    LitCovid-PMC-OGER-BB

    {"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T1650","span":{"begin":8,"end":16},"obj":"GO:0007567"},{"id":"T1651","span":{"begin":36,"end":45},"obj":"GO:0007565"},{"id":"T1652","span":{"begin":79,"end":87},"obj":"GO:0007565"},{"id":"T1653","span":{"begin":122,"end":127},"obj":"UBERON:0002113"},{"id":"T1654","span":{"begin":209,"end":214},"obj":"GO:0016265"},{"id":"T1655","span":{"begin":295,"end":303},"obj":"GO:0007565"},{"id":"T15506","span":{"begin":392,"end":405},"obj":"GO:0007567"},{"id":"T72776","span":{"begin":407,"end":415},"obj":"GO:0007567"},{"id":"T85174","span":{"begin":571,"end":575},"obj":"SP_10"},{"id":"T1659","span":{"begin":583,"end":591},"obj":"GO:0007565"},{"id":"T1660","span":{"begin":624,"end":629},"obj":"UBERON:0000178"},{"id":"T1661","span":{"begin":631,"end":639},"obj":"UBERON:0001987"},{"id":"T1662","span":{"begin":641,"end":647},"obj":"UBERON:0000310"},{"id":"T87042","span":{"begin":648,"end":652},"obj":"UBERON:0001913"},{"id":"T17765","span":{"begin":666,"end":677},"obj":"GO:0042571"},{"id":"T97868","span":{"begin":764,"end":774},"obj":"GO:0007596"},{"id":"T40317","span":{"begin":921,"end":930},"obj":"GO:0007567;UBERON:0012101"}],"text":"Pregnant women with symptomatic MERS-CoV infection may be at a higher risk of adverse events. There are 9 reported cases of symptomatic MERS-CoV in pregnant women, and 7 of them required ICU admission, 5 required mechanical ventilation, and 3 died (Table 8).138 One case report of a term delivery in a recovered patient and another report of a patient delivered preterm while in the active phase of infection showed negative viral testing in the infant.138 , 139 There are 2 reported cases of asymptomatic MERS-CoV infection in pregnant women, both identified via contact tracing. One was identified at 6 weeks gestation, and the other at 24 weeks. Both had healthy term deliveries.140 Based on available epidemiologic data, it is unclear whether pregnant women with MERS-CoV have worse outcomes, though 3 deaths among eleven reported cases are concerning compared to an 8.9% death rate reported in a nonpregnant female population.141"}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"1912","span":{"begin":9,"end":14},"obj":"Species"},{"id":"1913","span":{"begin":136,"end":144},"obj":"Species"},{"id":"1914","span":{"begin":157,"end":162},"obj":"Species"},{"id":"1915","span":{"begin":312,"end":319},"obj":"Species"},{"id":"1916","span":{"begin":344,"end":351},"obj":"Species"},{"id":"1917","span":{"begin":537,"end":542},"obj":"Species"},{"id":"1918","span":{"begin":756,"end":761},"obj":"Species"},{"id":"1919","span":{"begin":767,"end":775},"obj":"Species"},{"id":"1920","span":{"begin":32,"end":50},"obj":"Disease"},{"id":"1921","span":{"begin":243,"end":247},"obj":"Disease"},{"id":"1922","span":{"begin":399,"end":408},"obj":"Disease"},{"id":"1923","span":{"begin":506,"end":524},"obj":"Disease"},{"id":"1924","span":{"begin":806,"end":812},"obj":"Disease"},{"id":"1925","span":{"begin":876,"end":881},"obj":"Disease"}],"attributes":[{"id":"A1912","pred":"tao:has_database_id","subj":"1912","obj":"Tax:9606"},{"id":"A1913","pred":"tao:has_database_id","subj":"1913","obj":"Tax:1335626"},{"id":"A1914","pred":"tao:has_database_id","subj":"1914","obj":"Tax:9606"},{"id":"A1915","pred":"tao:has_database_id","subj":"1915","obj":"Tax:9606"},{"id":"A1916","pred":"tao:has_database_id","subj":"1916","obj":"Tax:9606"},{"id":"A1917","pred":"tao:has_database_id","subj":"1917","obj":"Tax:9606"},{"id":"A1918","pred":"tao:has_database_id","subj":"1918","obj":"Tax:9606"},{"id":"A1919","pred":"tao:has_database_id","subj":"1919","obj":"Tax:1335626"},{"id":"A1920","pred":"tao:has_database_id","subj":"1920","obj":"MESH:D018352"},{"id":"A1921","pred":"tao:has_database_id","subj":"1921","obj":"MESH:D003643"},{"id":"A1922","pred":"tao:has_database_id","subj":"1922","obj":"MESH:D007239"},{"id":"A1923","pred":"tao:has_database_id","subj":"1923","obj":"MESH:D018352"},{"id":"A1924","pred":"tao:has_database_id","subj":"1924","obj":"MESH:D003643"},{"id":"A1925","pred":"tao:has_database_id","subj":"1925","obj":"MESH:D003643"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Pregnant women with symptomatic MERS-CoV infection may be at a higher risk of adverse events. There are 9 reported cases of symptomatic MERS-CoV in pregnant women, and 7 of them required ICU admission, 5 required mechanical ventilation, and 3 died (Table 8).138 One case report of a term delivery in a recovered patient and another report of a patient delivered preterm while in the active phase of infection showed negative viral testing in the infant.138 , 139 There are 2 reported cases of asymptomatic MERS-CoV infection in pregnant women, both identified via contact tracing. One was identified at 6 weeks gestation, and the other at 24 weeks. Both had healthy term deliveries.140 Based on available epidemiologic data, it is unclear whether pregnant women with MERS-CoV have worse outcomes, though 3 deaths among eleven reported cases are concerning compared to an 8.9% death rate reported in a nonpregnant female population.141"}

    2_test

    {"project":"2_test","denotations":[{"id":"32620220-28875620-2074258","span":{"begin":258,"end":261},"obj":"28875620"},{"id":"32620220-28875620-2074259","span":{"begin":453,"end":456},"obj":"28875620"},{"id":"32620220-26936356-2074260","span":{"begin":459,"end":462},"obj":"26936356"},{"id":"32620220-29907538-2074261","span":{"begin":682,"end":685},"obj":"29907538"},{"id":"32620220-27358348-2074262","span":{"begin":931,"end":934},"obj":"27358348"}],"text":"Pregnant women with symptomatic MERS-CoV infection may be at a higher risk of adverse events. There are 9 reported cases of symptomatic MERS-CoV in pregnant women, and 7 of them required ICU admission, 5 required mechanical ventilation, and 3 died (Table 8).138 One case report of a term delivery in a recovered patient and another report of a patient delivered preterm while in the active phase of infection showed negative viral testing in the infant.138 , 139 There are 2 reported cases of asymptomatic MERS-CoV infection in pregnant women, both identified via contact tracing. One was identified at 6 weeks gestation, and the other at 24 weeks. Both had healthy term deliveries.140 Based on available epidemiologic data, it is unclear whether pregnant women with MERS-CoV have worse outcomes, though 3 deaths among eleven reported cases are concerning compared to an 8.9% death rate reported in a nonpregnant female population.141"}